Scinai Immunotherapeutics Ltd.
About Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.3M
- Net income
- -$8.3M
- Total assets
- $11.6M
- Market cap
- $1.6M
Source: SEC EDGAR · updated Jun 8, 2026
- Market cap
- $1.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 12, 2015
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Scinai Immunotherapeutics Ltd..
